Fig. 2From: Integrated analysis identifies GABRB3 as a biomarker in prostate cancerKaplan–Meier estimation displays overall survival (A) and cancer-specific survival (B) among patients with prostate cancer categorized based on the genotypes of GABRB3 rs12591845. The values in parentheses indicate the patient count within each subgroupBack to article page